By expenditures
| Name | Title | Type |
|---|---|---|
| Hsu-Feng Andy Shaw | Executive Director | Auditee |
| Sean Barrera | FEE ACCOUNTANT | Auditee |
| Jim Evans | Interim Executive Director | Auditee |
| Mandy Merchant | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 338916 | 2024 | 2025-01-20 | Cliftonlarsonallen LLP | $14.04M |
| 13226 | 2023 | 2024-01-23 | Cliftonlarsonallen LLP | $11.56M |
| 19862 | 2022 | 2023-03-26 | Cliftonlarsonallen | $10.01M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 338916 | 2024 | 2025-01-20 | 1096221 | 2024-001 | Significant Deficiency | Yes | N |
| 338916 | 2024 | 2025-01-20 | 1096220 | 2024-001 | Significant Deficiency | Yes | N |
| 338916 | 2024 | 2025-01-20 | 519779 | 2024-001 | Significant Deficiency | Yes | N |
| 338916 | 2024 | 2025-01-20 | 519778 | 2024-001 | Significant Deficiency | Yes | N |
| 13226 | 2023 | 2024-01-23 | 586015 | 2023-003 | Material Weakness | Yes | N |
| 13226 | 2023 | 2024-01-23 | 586014 | 2023-003 | Material Weakness | Yes | N |
| 13226 | 2023 | 2024-01-23 | 586013 | 2023-002 | Significant Deficiency | Yes | N |
| 13226 | 2023 | 2024-01-23 | 586012 | 2023-002 | Significant Deficiency | Yes | N |
| 13226 | 2023 | 2024-01-23 | 586011 | 2023-001 | Significant Deficiency | Yes | E |
| 13226 | 2023 | 2024-01-23 | 586010 | 2023-001 | Significant Deficiency | Yes | E |
| 13226 | 2023 | 2024-01-23 | 9573 | 2023-003 | Material Weakness | Yes | N |
| 13226 | 2023 | 2024-01-23 | 9572 | 2023-003 | Material Weakness | Yes | N |
| 13226 | 2023 | 2024-01-23 | 9571 | 2023-002 | Significant Deficiency | Yes | N |
| 13226 | 2023 | 2024-01-23 | 9570 | 2023-002 | Significant Deficiency | Yes | N |
| 13226 | 2023 | 2024-01-23 | 9569 | 2023-001 | Significant Deficiency | Yes | E |
| 13226 | 2023 | 2024-01-23 | 9568 | 2023-001 | Significant Deficiency | Yes | E |
| 19862 | 2022 | 2023-03-26 | 600317 | 2022-004 | Significant Deficiency | Yes | N |
| 19862 | 2022 | 2023-03-26 | 600316 | 2022-003 | Material Weakness | Yes | N |
| 19862 | 2022 | 2023-03-26 | 600315 | 2022-002 | Significant Deficiency | Yes | N |
| 19862 | 2022 | 2023-03-26 | 600314 | 2022-001 | Significant Deficiency | Yes | E |
| 19862 | 2022 | 2023-03-26 | 600313 | 2022-004 | Significant Deficiency | Yes | N |
| 19862 | 2022 | 2023-03-26 | 600312 | 2022-003 | Material Weakness | Yes | N |
| 19862 | 2022 | 2023-03-26 | 600311 | 2022-002 | Significant Deficiency | Yes | N |
| 19862 | 2022 | 2023-03-26 | 600310 | 2022-001 | Significant Deficiency | Yes | E |
| 19862 | 2022 | 2023-03-26 | 23875 | 2022-004 | Significant Deficiency | Yes | N |
| 19862 | 2022 | 2023-03-26 | 23874 | 2022-003 | Material Weakness | Yes | N |
| 19862 | 2022 | 2023-03-26 | 23873 | 2022-002 | Significant Deficiency | Yes | N |
| 19862 | 2022 | 2023-03-26 | 23872 | 2022-001 | Significant Deficiency | Yes | E |
| 19862 | 2022 | 2023-03-26 | 23871 | 2022-004 | Significant Deficiency | Yes | N |
| 19862 | 2022 | 2023-03-26 | 23870 | 2022-003 | Material Weakness | Yes | N |
| 19862 | 2022 | 2023-03-26 | 23869 | 2022-002 | Significant Deficiency | Yes | N |
| 19862 | 2022 | 2023-03-26 | 23868 | 2022-001 | Significant Deficiency | Yes | E |